A phase II randomised study to evaluate the efficacy of aprepitant plus palonosetron for preventing delayed‐phase CINV associated with TC therapy in gynaecological cancer
- Resource Type
- Academic Journal
- Source
- Journal of Obstetrics and Gynaecology Research. Sep 01, 2017 43(9):1454-1459
- Subject
- Language
- English
- ISSN
- 1341-8076